Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

MOCRU and its partner Medical Action Myanmar (MAM) have begun a study to identify areas in Myanmar where Burkholderia pseudomallei is present in the soil and where people are at risk of melioidosis, a difficult to diagnose deadly bacterial disease.

Composite photo of researchers analysing the soil for melioisodis bacteria (B. pseudomallei) in Myanmar

MOCRU Director Frank Smithuis is Principal Investigator for the study, which will take 2,000 samples from 200 locations across Myanmar and then look at hospitals where B. pseudomallei seems prevalent and see if it can confirm melioidosis in patients. The Dept of Medical research will do the microbiology for the study.

A highly pathogenic bacterium commonly found in soil and water in South and Southeast Asia and endemic in northeast Thailand and northern Australia, B. pseudomallei causes melioidosis. Contracted through the skin, lungs or by drinking contaminated water, melioidosis is difficult to diagnose as it mimics other diseases. B. pseudomallei is resistant to a wide range of antimicrobials, and a cause of sepsis with a high mortality rate (50-90% depending on level of care available).  

Although melioidosis was first described in Rangoon (Yangon) in 1912, the distribution of B. pseudomallei in soil and the extent of melioidosis in Myanmar remains largely unknown. Local studies have confirmed the presence of B. pseudomallei in soil and confirmed clinical cases of melioidosis in Yangon. Other melioidosis cases have been found on the Thai-Myanmar border.

Funded by MAM, the study will run for 6-12 months and contribute to the global mapping of B. pseudomallei.

A landmark 2016 study by MORU’s Direk Limmathurotsakul that predicted that melioidosis is likely to be present in many more countries than previously thought, estimated that there may have been up to 6,247 melioidosis cases resulting in 3,687 deaths in Myanmar in 2015.

-Text and photos courtesy of Frank Smithuis and Liz Ashley

Similar stories

MORU hepatitis work focusses on preventing mother-to-child transmission, high-at-risk populations, and remote communities

MORU Tropical Health Network researchers in Southeast Asia study various aspects of hepatitis B and C, infections that can lead to chronic liver diseases, and complications like liver cancer or cirrhosis. Researchers at MOCRU work on treatment for hepatitis C, a frequent opportunistic infection in HIV patients. MORU’s Clinical Pharmacology conducts two trials on possible treatments of hepatitis C. Hepatitis B is frequently transmitted from mother to child at birth, and SMRU researchers study mothers’ knowledge and behaviour, as well as prevention.

Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis

Patients affected by COVID-19 should be treated according to the severity of their disease. However, not all key national or international organisations define severity in the same way. This imprecision in severity assessment compromises the validity of some therapeutic recommendations. Using individual patient data would better guide and improve therapeutic recommendations for COVID-19.

Field evaluation of EasyScan GO: a digital malaria microscopy device

Microscopic examination of Giemsa-stained blood films is key to quantifying and detecting malaria parasites but there can be difficulties in ensuring both a high-quality manual reading and inter-reader reliability. The EasyScan GO was developed as a potential solution to this, a microscopy device using machine-learning-based image analysis for automated parasite detection and quantification.

Enhanced vaccination against Japanese encephalitis virus could reduce encephalitis prevalence by one third in SE Asia

Encephalitis is a worldwide public health issue, with a substantially high burden among children in Southeast Asia. A large study of the causes of childhood encephalitis in SE Asia suggests that enhanced and effective vaccination against the Japanese encephalitis virus alone could reduce encephalitis prevalence by one third.

Congratulations to Professor Sir David Warrell, appointed Knight Commander of the Order of St Michael and St George!

David Warrell, MORU founding director, has been appointed by the Queen ‘Knight Commander of the Order of St Michael and St George for services to global Health Research and Clinical Practice’. Please join us in congratulating Sir David on receiving this richly deserved high honour!

Laos’ first Pint of Science: warty newts, COVID, AI for Instagram, and more!

Organised by a grass-root community of thousands of scientists across the world, Pint of Science 2022 allows researchers in 25 countries and over 800 cities to share their latest findings with lay folk in interesting, informal settings. Lao PDR joined the global Pint of Science family on Monday 9 May, when the first-ever Pint of Science Laos kicked off!